![BeardBros_BlogImages [Recovered]](data:image/svg+xml;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMjU2MCAyOTIiIHdpZHRoPSIyNTYwIiBoZWlnaHQ9IjI5MiIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48L3N2Zz4=)
Key Takeaways
- BelCosta Labs faced a sudden shutdown by the DCC due to serious allegations of regulatory violations, leading to an immediate operational suspension.
- The DCC denied BelCosta’s annual license application shortly after offering a review, raising concerns about due process and fairness.
- Despite proving some regulatory violations, the judge found no malicious intent or actual harm, deeming the DCC’s punitive decision excessive.
- The situation highlights the need for timely reviews and clear corrective paths to protect businesses from disproportionate enforcement actions.
- BelCosta’s case illustrates how regulatory actions can have severe economic consequences, impacting jobs and operational viability without proper due process.
BelCosta Labs Long Beach was not a fly-by-night testing operation. According to the July 24, 2026 proposed decision from the California Office of Administrative Hearings, BelCosta was among the first laboratories to receive a provisional license from the state. It earned ISO/IEC 17025 accreditation in 2018, passed subsequent ISO audits, operated for nearly seven years under a provisional license, and had only one prior citation during that period.
In its final year of operation, BelCosta employed more than 70 people and processed over 18,400 customer samples. Owner Myron Ronay testified that the company completed 85,226 compliance tests over its operating history.
Then the DCC pulled the plug.
On April 10, 2025, the agency issued an immediate suspension of BelCosta’s provisional cannabis testing laboratory license. The notice ordered the company to stop all licensed activity, including testing and transporting or transferring cannabis products. The DCC alleged seven categories of violations involving microbial and potency reporting, delayed uploads to California’s track-and-trace system, chain-of-custody records, shared system credentials, sampling procedures, and employee qualifications.
Those allegations were serious. Laboratory integrity is the legal market’s firewall between contaminated or mislabeled products and consumers. Regulators should investigate credible concerns aggressively. But an investigation is not the same thing as a proven case, and an allegation is not a final finding.
That distinction matters when the government’s interim action can destroy the business before neutral review occurs.
The DCC Offered a Review and Then Denied the License the Same Day
BelCosta responded quickly. With help from laboratory accreditation expert Dr. Susan Audino, the company conducted an internal review and submitted a 38-page response on April 15, addressing each allegation and describing completed or planned corrective actions.
On April 29, the DCC issued a Notice of Provisional License Review. According to the proposed decision, that notice acknowledged BelCosta’s response, offered an opportunity to request a meeting, and said the agency would complete its review no sooner than five business days after the notice date. It recommended that BelCosta submit relevant information or request a meeting within three business days.
Then, shortly after issuing that notice on the very same day, the DCC denied BelCosta’s annual license application. It did not meet with BelCosta after offering the review opportunity.
Read that again. The agency described a multi-day review process and then reached the outcome within hours.
Whether that sequence satisfies the minimum legal requirements is one question. Whether it resembles fair, competent regulation is another. If an agency offers a business a chance to be heard while the denial paperwork is apparently already moving out the door, the process starts to look less like meaningful review and more like regulatory theater.
The annual-license denial also canceled BelCosta’s provisional license by operation of law. What began as an immediate suspension became a prolonged inability to operate.
BelCosta Sued the DCC but Did Not Win That Court Case
Some coverage has blurred two different proceedings, so the record needs to be clear.
BelCosta filed a petition against the DCC in Sacramento County Superior Court on April 18, 2025, seeking to recover its suspended license and arguing that the agency had acted without adequate due process. Contemporary reporting quoted the petition’s warning that the suspension had shuttered a multimillion-dollar business and put it in danger of closing permanently.
The court did not ultimately restore the license in that proceeding. Sacramento Superior Court’s public docket lists the matter—case number 25WM000064—as disposed on May 23, 2025 with a court finding of “Denied.” WeedWeek later reported that the judge had expressed concern about whether BelCosta received due process, but concern was not the emergency relief the company needed to keep its people working.
The favorable July 2026 result came from a separate administrative licensing case before the Office of Administrative Hearings, not from BelCosta winning the 2025 Superior Court lawsuit.
That correction does not weaken the criticism of the DCC. It exposes the real problem: the company remained shut down while the slower administrative process—the process that finally tested the allegations through evidence and testimony—continued for more than a year.
What the Administrative Law Judge Actually Found
Administrative Law Judge Cindy F. Forman heard the case over four days in March 2026. The decision that followed was not a blanket exoneration of BelCosta. The DCC proved five regulatory violations related to laboratory practices and track-and-trace reporting.
Those violations should not be minimized. The proposed decision identified problems including untimely compliance-test reporting, incomplete chain-of-custody documentation, improper sharing of California Cannabis Track-and-Trace login credentials, a representative-sampling violation, and an employee-qualification issue.
But the judge also rejected the DCC’s attempt to turn those findings into a justification for permanent business extinction.
The decision found no evidence of malicious intent, fraud, or deception. It found no proven actual harm to the public or any consumer. It noted that BelCosta took corrective action, including assigning individual track-and-trace credentials and dismissing a sampler after learning the employee lacked required qualifications. It also credited BelCosta’s continuing work with an accreditation expert and its willingness to undertake additional training and testing.
Most significantly, the decision states that the DCC did not substantiate at hearing any of approximately 20 mostly anonymous complaints it received from people claiming to be current or former BelCosta employees.
The judge classified the proven conduct as Tier 1 and Tier 2 violations—not the Tier 3 category associated with knowing or willful violations and fraud. Under the DCC’s own disciplinary framework, the lower tiers can support suspensions and fines. Yet the agency pursued denial of the annual license, an outcome that would end BelCosta’s ability to operate in California.
The proposed decision called that result “unduly punitive.” It concluded that public safety could be protected by issuing an annual license, immediately staying its revocation, and placing BelCosta on probation for three years.
That is not a finding that BelCosta did everything right. It is a finding that the DCC’s chosen punishment did not fit the case it could actually prove.
Regulation Cannot Be Allowed to Become Economic Execution Without Timely Review
The DCC will understandably argue that cannabis testing failures can create real public-health risks. That is true. Aspergillus, pesticides, inaccurate potency results, broken chain-of-custody procedures, and weak sampling practices are not paperwork trivia. The state has an obligation to protect patients and adult-use consumers.
But public safety does not require procedural recklessness.
Regulators have a range of tools: corrective-action orders, targeted product holds, independent retesting, enhanced audits, fines, monitored probation, temporary restrictions, and suspensions proportionate to verified risk. The proposed decision itself concluded that probation could adequately protect the public.
Instead, the DCC imposed an immediate operational shutdown before a full evidentiary hearing, denied the annual license 19 days later, and left BelCosta to fight for more than a year. By the time the administrative judge recommended a license, the remedy had become brutally abstract.
A laboratory is not a light switch. It cannot simply be turned off for 15 months and then expected to illuminate the same room.
Customers move. Scientists, analysts, samplers, administrative staff, and salespeople find other work. Instruments sit idle. Leases, insurance, accreditation, software, debt, and legal expenses continue. Relationships built over years disappear in weeks. Even if the DCC adopts the proposed decision, it cannot order the market to return BelCosta’s customers. It cannot recreate the team. It cannot give workers back the income, health coverage, stability, and time they lost.
This is where California’s regulatory model fails its own legal industry. The state demands that cannabis companies act like mature, compliant businesses while reserving the power to destabilize them through processes no ordinary business could financially survive.
More Than 70 Jobs Were Not a Footnote
The proposed decision records that BelCosta had more than 70 employees in its last year of operation. Those workers were not allegations, license numbers, or line items in an enforcement memo. They were chemists, technicians, sample collectors, quality personnel, administrators, and families whose livelihoods depended on a functioning company.
There is no indication in the proposed decision that those employees caused consumer harm. Yet they absorbed the immediate consequences of the DCC’s enforcement choice long before an administrative judge weighed the full record.
Government agencies routinely speak about protecting the public. Workers in the regulated cannabis industry are also members of that public.
Due process delayed is not an academic inconvenience when payroll stops. A later ruling can clarify the law, vindicate an owner’s position in part, or recommend a license. It cannot make a laid-off worker whole. It cannot reimburse a family for missed rent. It cannot restore a career disrupted by an agency action later found disproportionate.
The DCC Still Controls What Happens Next
The July decision is proposed, not final. The DCC’s own notice says it received the proposed decision on July 24 and has 100 days to adopt it, modify it, or reject it under California Government Code section 11517. As of August 8, 2026, BelCosta does not appear on the DCC’s published final-decisions page for this matter.
That means headlines claiming the license has already been restored go further than the public record supports.
The DCC now faces a basic test of institutional credibility. It can adopt a decision that acknowledges proven violations, imposes serious oversight, and rejects a punishment the judge found excessive. Or it can prolong a fight after the company and its workers have already paid a price no three-year probation order can reverse.
If the agency modifies or rejects the proposed decision, it should explain publicly and specifically why. “Public safety” cannot function as a magic phrase that ends all scrutiny. The public deserves to know which factual findings the agency disputes, what evidence supports its position, why probation is inadequate, and how its process will prevent irreversible harm before neutral review.
California Needs Enforcement That Protects Consumers Without Destroying Due Process
The BelCosta case should force reform.
First, immediate shutdowns should require a documented, specific, and imminent risk—not merely a collection of allegations that may take more than a year to adjudicate. When a full shutdown is necessary, an expedited evidentiary hearing should follow in days or weeks, not after the business has already been economically buried.
Second, the DCC should be required to identify a clear path to reinstatement whenever alleged violations are correctable. A suspension notice that shuts every door without explaining how to reopen one is not compliance assistance. It is a sentence.
Third, independent review must occur before an interim enforcement action becomes a permanent commercial reality. The regulator should not be investigator, prosecutor, executioner, and clock manager while a licensee’s survival drains away.
Fourth, California should track and disclose the economic effects of enforcement actions later reversed or materially reduced: jobs lost, businesses closed, time to hearing, allegations abandoned, and violations ultimately proved. Agencies measure enforcement outputs. They should also measure collateral damage.
Finally, there must be accountability when the state chooses a penalty far more destructive than the one supported after hearing. That does not necessarily mean personal liability for individual staff. It does mean legislative oversight, public reporting, enforceable deadlines, and a meaningful remedy for businesses damaged by disproportionate interim action.
The Bottom Line on BelCosta Labs and the DCC
BelCosta was not found violation-free. The DCC proved legitimate compliance failures, and those failures warranted correction and oversight.
What the agency did not prove was the case for erasing the company.
The administrative judge found no demonstrated actual harm to consumers, no malicious intent, no fraud or deception, and no substantiated anonymous complaints at hearing. She found that BelCosta corrected practices and that three years of probation could protect the public. Denial of the annual license, she concluded, was “unduly punitive.”
That phrase should haunt the DCC, because “unduly punitive” is sterile government language for a punishment that went too far. In the real world, going too far meant a major testing laboratory stopped operating, more than 70 jobs were put at risk or lost, customers scattered, and a company spent over a year fighting toward a license that may arrive after the enterprise it was meant to authorize could no longer be saved.
California cannot build a sustainable legal cannabis market on enforcement by irreversible surprise. Protect consumers. Enforce testing standards. Penalize proven violations. But give operators a prompt, honest chance to answer allegations before the punishment becomes the verdict.
Anything less is not responsible regulation. It is prohibition wearing a state badge.
Frequently Asked Questions
The DCC immediately suspended BelCosta’s provisional cannabis testing license on April 10, 2025 after alleging seven categories of violations involving testing results, track-and-trace reporting, chain-of-custody records, login credentials, sample collection, and employee qualifications. It denied the company’s annual license application on April 29, which canceled the provisional license by operation of law.
No. BelCosta’s 2025 Sacramento Superior Court proceeding was disposed with a denied finding. The favorable result reported in July 2026 was a proposed decision in a separate administrative licensing case. That decision recommends that the DCC issue BelCosta an annual license on three years of probation.
No. The administrative law judge found that the DCC proved five regulatory violations. However, the judge also found no proven actual harm to consumers, no malicious intent, fraud, or deception, significant corrective and mitigating evidence, and that denying the annual license was unduly punitive.
Not finally as of August 8, 2026. The Office of Administrative Hearings issued a proposed decision. The DCC stated that it has 100 days from July 24, 2026 to adopt, modify, or reject that decision.
The proposed administrative decision states that BelCosta employed more than 70 people in its last year of operation and processed more than 18,400 customer samples during that year.
California should provide faster independent hearings after emergency cannabis-license suspensions, publish clear corrective paths, use penalties proportionate to proven risks, and account publicly for jobs and businesses lost when severe interim enforcement is later reduced.
